Neurons exhibiting dopamine D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse

Neuroscience

Volumn 89, Issue 1, 1999, Pages 191-207

  Xu, S G ^a   Prasad, C ^a   Smith, D E ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Dendrites; Midbrain; Parkinson's disease; Ultrastructure

Indexed keywords

ACROLEIN; ANTISERUM; DOPAMINE; DOPAMINE 2 RECEPTOR; PARAFORMALDEHYDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; MOUSE; MOUSE MUTANT; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; CELL DEATH; DENDRITES; MICE; MICE, NEUROLOGIC MUTANTS; MICROSCOPY, ELECTRON; NEURONS; PARKINSON DISEASE; PRESYNAPTIC TERMINALS; RECEPTORS, DOPAMINE D2; SUBSTANTIA NIGRA; SYNAPSES; TYROSINE 3-MONOOXYGENASE;

EID: 0033105952     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00286-3     Document Type: Article

References (60)

1. Aghajanian G. K. and Buney B. S. (1977) Dopamine "autoreceptors": Pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-schmiedeberg's Arch. Pharmac. 297, 1-7.
2. Agid Y., Javoy-Agid F. and Ruberg M. (1987) Biochemistry of neurotransmitters in Parkinson's disease. In Movement Disorders (eds Marsden C. D. and Fahn S.), pp. 166-230. Butterworths, London.
3. Arbilla S. and Langer S. Z. (1981) Stereoselectivity of presynaptic autoreceptors modulating dopamine release. Eur. J. Pharmac. 76, 345-351.
4. 2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera. Brain Res. 609, 71-80.
5. 2 dopamine receptor localization on striatonigral neurons. Neurosci. Lett. 144, 215-220.
6. Bayer S. A., Triarhou L. C., Thomas J. D. and Ghetti B. (1994) Correlated quantitative studies of the neostriatum, nucleus accumbens, substantia nigra, and ventral tegmental area in normal and weaver mutant mice. J. Neurosci. 14, 6901-6910.
7. Bayer S. A., Wills K. V., Triarhou L. C., Thomas J. D. and Ghetti B. (1995) Systematic differences in time of dopaminergic neuron origin between normal mice and homozygous weaver mutants. Expl Brain Res. 105, 200-208.
8. Beckstead R. M., Wooten G. F. and Trugman J. M. (1988) Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography. J. Comp. Neurol. 268, 131-145.
9. Bevan M. D., Smith A. D. and Bolam J. P. (1996) The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat. Neuroscience 75, 5-12.
10. 2 receptor binding in the substantia nigra following intrastriatal injection of a retrograde neurotoxin (volkensin). Neurosci. Lett. 134, 180-182.
11. Bolam P. and Smith Y. (1991) Characterization of the synaptic inputs to dopaminergic neurones in the rat substantia nigra. In The Basal Ganglia III (eds Bernardi G. et al.), Vol. 39, pp. 119-131. Plenum, New York.
12. 125i]iodosulpiride. Neuroscience 20, 117-155.
13. 2 subtypes of dopamine receptors in the rat brain. J. Neurosci. 6, 3177-3188.
14. Brock J. W., Farooqui S., Ross K. and Prasad C. (1992) Localization of dopamine D2 receptor protein in rat brain using polyclonal antibody. Brain Res. 578, 244-250.
15. Chan J., Aoki C. and Pickel V. M. (1990) Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J. Neurosci. Meth. 33, 113-127.
16. Cheramy A., Leviel V. and Glowinski J. (1981) Dendritic release of dopamine in the substantia nigra. Nature 289, 537-542.
17. Condė H. (1992) Organization and physiology of the substantia nigra. Expl Brain Res. 88, 233-248.
18. Domesick V. B., Stinus L. and Paskevich P. A. (1983) The cytology of dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area of the rat: A light- and electron-microscopic study. Neuroscience 8, 743-765.
19. Farooqui S. M., Brock J. W., Hamdi A. and Prasad C. (1991) Antibodies against synthetic peptides predicted from the nucleotide sequence of D2 receptor recognize native dopamine receptor protein in rat striatum. J. Neurochem. 57, 1363-1369.
20. 2 dopamine receptor protein location: Golgi impregnation-gold toned and ultrastructural analysis of the rat neostriatum. J. Neurosci. Res. 38, 551-564.
21. Forno L. S., DeLanney L. E., Irwin I. and Langston J. W. (1994) Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey. Molec. Neurobiol. 9, 163-170.
22. Gerfen C. R., Herkenham M. and Thibault J. (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7, 3915-3934.
23. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254.
24. Graybiel A. M., Hirsch E. C. and Agid Y. (1990) The nigrostriatal system in Parkinson's disease. In Parkinson's Disease: Anatomy, Pathology and Therapy (eds Streifler M. B., Korczyn A. D., Melamed E. and Youdim M. B. H.), Vol. 53, pp. 17-29. Raven, New York.
25. Graybiel A. M., Ohta K. and Roffler-Tarlov S. (1990) Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments. J. Neurosci. 10, 720-733.
26. Groves P. M., Wilson C. J., Young S. J. and Rebec G. V. (1975) Self-inhibition by dopaminergic neurons. Science 190, 522-529.
27. Gupta M., Feiten D. L. and Ghetti B. (1987) Selective loss of monoaminergic neurons in weaver mutant mice - An immunocytochemical study. Brain Res. 402, 379-382.
28. Hsu S. M., Raine L. and Fanger H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
29. Joh T. H., Geghan C. and Reis D. J. (1973) Immunochemical demonstration of increased tyrosine hydroxylase protein in sympathetic ganglia and adrenal medulla elicited by reserpine. Proc. Natn. Acad. Sci. U.S.A. 70, 2767-2771.
30. Kaseda Y., Ghetti B., Low W. C., Richter J. A. and Simon J. R. (1987) Dopamine D2 receptors increase in the dorsolateral striatum of weaver mutant mice. Brain Res. 422, 178-181.
31. 2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natn. Acad. Sci. U.S.A. 90, 8861-8865.
32. 3H]sulpiride binding in the rat substantia nigra: Direct evidence for the existence of nigral D-2 autoreceptors. Eur. J. Pharmac. 140, 99-104.
33. Oo T. F., Blazeski R., Harrison S. M., Mason C. A., Roffler-Tarlov S. K. and Burke R. E. (1996) Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J. Neurosci. 16, 6134-6145.
34. Patil N., Cox D. R., Bhat D., Faham M., Myers R. M. and Peterson A. S. (1995) A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nature Genet. 11, 126-129.
35. Pickel V. M., Beckley S. C., Joh T. H. and Reis D. J. (1981) Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum. Brain Res. 225, 373-385.
36. Pucak M. L. and Grace A. A. (1994) Evidence that systemically administered dopamine antagonists activate dopamine firing primarily by blockade of somatodendritic autoreceptors. J. Pharmac. Exp. Ther. 271, 1181-1192.
37. Pucak M. L. and Grace A. A. (1996) Effects of haloperidol on the activity and membrane physiology of substantia nigra dopamine neurons recorded in vitro. Brain Res. 713, 44-52.
38. Pullara J. M. and Marshall J. F. (1989) Striatal dopamine innervation and receptor density: Regional effects of the weaver mutation. Brain Res. 480, 225-233.
39. Rakic P. and Sidman R. L. (1973) Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice. J. Comp. Neurol. 152, 103-132.
40. Rakic P. and Sidman R. L. (1973) Organization of cerebellar cortex secondary to deficit of granule cells in weaver mutant mice. J. Comp. Neurol. 152, 133-162.
41. Roffler-Tarlov S. and Graybiel A. M. (1984) Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and non-limbic striatum. Nature 307, 62-66.
42. Roffler-Tarlov S. and Graybiel A. M. (1986) Expression of the weaver gene in dopamine-containing neural systems is dose-dependent and affects both striatal and non-striatal regions. J. Neurosci. 6, 3319-3330.
43. Roffler-Tarlov S., Graybiel A. M. and Martin B. (1990) Genetic perturbation of dendrite formation. Soc. Neurosci. Abstr. 16, 932.
44. Roffler-Tarlov S., Martin B., Graybiel A. M. and Kauer J. S. (1996) Cell death in the midbrain of the murine mutation weaver. J. Neurosci. 16, 1819-1826.
45. 2-receptors in the striatum of the rat. Neurochem. Res. 17, 387-395.
46. Santiago M. and Westerink B. H. C. (1991) The regulation of dopamine release from nigrostriatal neurons in conscious rats: The role of somatodendritic autoreceptors. Eur. J. Pharmac. 204, 79-85.
47. Sato T. (1968) A modified method for lead staining of thin sections. J. Electron Microsc. 17, 158-159.
48. Schachner M., Hedley-White E. T., Hse D. W., Schoonmaker G. and Bignami A. (1977) Ultrastructural localization of glial fibrillary acid protein in mouse cerebellum by immunoperoxidase labeling. J. Cell Biol. 75, 67-73.
49. Schmidt M. J., Sawyer B. D., Perry K. W., Fuller R. W., Foreman M. M. and Ghetti B. (1982) Dopamine deficiency in the weaver mutant mouse. J. Neurosci. 2, 376-380.
50. 2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88-106.
51. 2 Dopamine Receptor Interactions (ed. Waddington J.), pp. 1-22. Academic, San Diego.
52. Sidman R. L., Angevine J. B. Jr and Pierce E. T. (1971) Atlas of The Mouse Brain and Spinal Cord. Harvard University Press, Cambridge, MA.
53. Smith M. W. III, Cooper T. R., Joh T. H. and Smith D. E. (1990) Cell loss and class distribution of TH-I cells in the substantia nigra of the neurological mutant, weaver. Brain Res. 510, 242-250.
54. + current in cerebellar granule cells [see comments]. Proc. Natn. Acad. Sci. U.S.A. 93, 11,191-11,195.
55. Triarhou L. C. and Ghetti B. (1989) The dendritic dopamine projection of the substantia nigra: Phenotypic denominator of weaver gene action in hetero- and homozygosity. Brain Res. 501, 373-381.
56. Triarhou L. C., Norton J. and Ghetti B. (1988) Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Expl Brain Res. 70, 256-265.
57. Verney C., Febvret-Muzerelle A. and Gaspar P. (1995) Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse. Devl Brain Res. 89, 115-119.
58. Waszczak B. L. and Walters J. R. (1986) Endogenous dopamine can modulate inhibition of substantia nigra pars reticulata neurons elicited by GABA iontophoresis or striatal stimulation. J. Neurosci. 6, 120-126.
59. Watson M. L. (1958) Staining of tissue sections for electron microscopy with heavy metals. J. Biophys. Biochem. Cytol. 4, 475-478.
60. Westerink B. H. C., Boer P. D., Santiago M. and DeVries J. B. (1994) Do nerve terminals and cell bodies of nigrostriatal dopaminergic neurons of the rat contain similar receptors? Neurosci. Lett. 167, 109-112.